RELAPSED MULTIPLE MYELOMA
Clinical trials for RELAPSED MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for RELAPSED MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for myeloma patients: drug combo shows promise in early trial
Disease control OngoingThis study tests a new combination of three drugs (belantamab mafodotin, carfilzomib, and dexamethasone) in people whose multiple myeloma has returned and stopped responding to a previous treatment. The goal is to find the safest dose and see how well it controls the cancer. Abou…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Engineered immune cells take on Hard-to-Treat blood cancer
Disease control OngoingThis early-phase trial tests a personalized cell therapy (CAR T) that targets a protein called BCMA on myeloma cells. It is for people whose multiple myeloma has returned or not responded to at least three prior treatments. The main goal is to check safety and find the right dose…
Matched conditions: RELAPSED MULTIPLE MYELOMA
Phase: PHASE1 • Sponsor: Thomas Martin, MD • Aim: Disease control
Last updated May 15, 2026 11:53 UTC